These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 28704273)
1. Anxiety does not contribute to social withdrawal in the subchronic phencyclidine rat model of schizophrenia. Seillier A; Giuffrida A Behav Pharmacol; 2017 Oct; 28(7):512-520. PubMed ID: 28704273 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of fatty-acid amide hydrolase and CB1 receptor antagonism differentially affect behavioural responses in normal and PCP-treated rats. Seillier A; Advani T; Cassano T; Hensler JG; Giuffrida A Int J Neuropsychopharmacol; 2010 Apr; 13(3):373-86. PubMed ID: 19607756 [TBL] [Abstract][Full Text] [Related]
3. Disruption of social cognition in the sub-chronic PCP rat model of schizophrenia: Possible involvement of the endocannabinoid system. Seillier A; Giuffrida A Eur Neuropsychopharmacol; 2016 Feb; 26(2):298-309. PubMed ID: 26706691 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of fatty acid amide hydrolase modulates anxiety-like behavior in PCP-treated rats. Seillier A; Giuffrida A Pharmacol Biochem Behav; 2011 Jun; 98(4):583-6. PubMed ID: 21421000 [TBL] [Abstract][Full Text] [Related]
5. Male rats treated with subchronic PCP show intact olfaction and enhanced interest for a social odour in the olfactory habituation/dishabituation test. Tarland E; Brosda J Behav Brain Res; 2018 Jun; 345():13-20. PubMed ID: 29477413 [TBL] [Abstract][Full Text] [Related]
6. Short- and long-term behavioral analysis of social interaction, ultrasonic vocalizations and social motivation in a chronic phencyclidine model. Peters SM; Tuffnell JA; Pinter IJ; van der Harst JE; Spruijt BM Behav Brain Res; 2017 May; 325(Pt A):34-43. PubMed ID: 28235589 [TBL] [Abstract][Full Text] [Related]
7. Distinct neuronal activation patterns are associated with PCP-induced social withdrawal and its reversal by the endocannabinoid-enhancing drug URB597. Matricon J; Seillier A; Giuffrida A Neurosci Res; 2016 Sep; 110():49-58. PubMed ID: 27091613 [TBL] [Abstract][Full Text] [Related]
8. Investigating the long-term effect of subchronic phencyclidine-treatment on novel object recognition and the association between the gut microbiota and behavior in the animal model of schizophrenia. Pyndt Jørgensen B; Krych L; Pedersen TB; Plath N; Redrobe JP; Hansen AK; Nielsen DS; Pedersen CS; Larsen C; Sørensen DB Physiol Behav; 2015 Mar; 141():32-9. PubMed ID: 25545766 [TBL] [Abstract][Full Text] [Related]
9. Subchronic treatment with phencyclidine in adolescence leads to impaired exploratory behavior in adult rats without altering social interaction or N-methyl-D-aspartate receptor binding levels. Metaxas A; Willems R; Kooijman EJ; Renjaän VA; Klein PJ; Windhorst AD; Donck LV; Leysen JE; Berckel BN J Neurosci Res; 2014 Nov; 92(11):1599-607. PubMed ID: 24953757 [TBL] [Abstract][Full Text] [Related]
11. PCP-induced deficits in murine nest building activity: employment of an ethological rodent behavior to mimic negative-like symptoms of schizophrenia. Pedersen CS; Sørensen DB; Parachikova AI; Plath N Behav Brain Res; 2014 Oct; 273():63-72. PubMed ID: 25064467 [TBL] [Abstract][Full Text] [Related]
12. Social interaction deficits caused by chronic phencyclidine administration are reversed by oxytocin. Lee PR; Brady DL; Shapiro RA; Dorsa DM; Koenig JI Neuropsychopharmacology; 2005 Oct; 30(10):1883-94. PubMed ID: 15798779 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of NMDA receptor models of schizophrenia: divergences in the behavioral effects of sub-chronic PCP and MK-801. Seillier A; Giuffrida A Behav Brain Res; 2009 Dec; 204(2):410-5. PubMed ID: 19716985 [TBL] [Abstract][Full Text] [Related]
14. Effects of cariprazine, a novel antipsychotic, on cognitive deficit and negative symptoms in a rodent model of schizophrenia symptomatology. Neill JC; Grayson B; Kiss B; Gyertyán I; Ferguson P; Adham N Eur Neuropsychopharmacol; 2016 Jan; 26(1):3-14. PubMed ID: 26655189 [TBL] [Abstract][Full Text] [Related]
15. Phencyclidine decreases tickling-induced 50-kHz ultrasound vocalizations in juvenile rats: a putative model of the negative symptoms of schizophrenia? Boulay D; Ho-Van S; Bergis O; Avenet P; Griebel G Behav Pharmacol; 2013 Oct; 24(7):543-51. PubMed ID: 23928693 [TBL] [Abstract][Full Text] [Related]
16. Chronic infusion of PCP via osmotic mini-pumps: a new rodent model of cognitive deficit in schizophrenia characterized by impaired attentional set-shifting (ID/ED) performance. Pedersen CS; Goetghebeur P; Dias R J Neurosci Methods; 2009 Dec; 185(1):66-9. PubMed ID: 19761795 [TBL] [Abstract][Full Text] [Related]
17. Dose-response effect of acute phencyclidine on functional connectivity and dopamine levels, and their association with schizophrenia-like symptom classes in rat. Paasonen J; Salo RA; Ihalainen J; Leikas JV; Savolainen K; Lehtonen M; Forsberg MM; Gröhn O Neuropharmacology; 2017 Jun; 119():15-25. PubMed ID: 28342897 [TBL] [Abstract][Full Text] [Related]
18. Phencyclidine and genetic animal models of schizophrenia developed in relation to the glutamate hypothesis. Enomoto T; Noda Y; Nabeshima T Methods Find Exp Clin Pharmacol; 2007 May; 29(4):291-301. PubMed ID: 17609743 [TBL] [Abstract][Full Text] [Related]
19. Differential effects of Δ9-tetrahydrocannabinol dosing on correlates of schizophrenia in the sub-chronic PCP rat model. Seillier A; Martinez AA; Giuffrida A PLoS One; 2020; 15(3):e0230238. PubMed ID: 32163506 [TBL] [Abstract][Full Text] [Related]
20. Analysis of sociability and preference for social novelty in the acute and subchronic phencyclidine rat. McKibben CE; Reynolds GP; Jenkins TA J Psychopharmacol; 2014 Oct; 28(10):955-63. PubMed ID: 25122039 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]